5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 8.73▲ | 8.73▲ | 8.73▲ | 8.88▲ | 7.65▲ |
MA10 | 8.52▲ | 8.36▲ | 8.28▲ | 8.56▲ | 7.28▲ |
MA20 | 7.80▲ | 7.52▲ | 7.45▲ | 7.67▲ | 7.92▲ |
MA50 | 6.88▲ | 6.88▲ | 6.92▲ | 7.31▲ | 9.51▼ |
MA100 | 6.87▲ | 6.68▲ | 6.68▲ | 7.90▲ | 13.29▼ |
MA200 | 6.57▲ | 7.02▲ | 6.98▲ | 9.00▲ | 36.77▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.113▲ | 0.175▲ | 0.203▲ | 0.193▲ | 0.279▲ |
RSI | 71.423▲ | 70.670▲ | 69.499▲ | 66.517▲ | 52.635▲ |
STOCH | 83.090▲ | 86.433▲ | 93.112▲ | 91.972▲ | 55.480 |
WILL %R | -13.527▲ | -10.487▲ | -9.180▲ | -7.796▲ | -19.335▲ |
CCI | 117.539▲ | 107.386▲ | 100.537▲ | 87.377 | 151.020▲ |
Thursday, June 26, 2025 05:00 PM
BOSTON, June 13, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation ...
|
Friday, June 13, 2025 04:30 AM
BOSTON, June 13, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation ...
|
Sunday, June 01, 2025 05:00 PM
Fintel reports that on June 2, 2025, B of A Securities upgraded their outlook for Boeing (SNSE:BACL) from Neutral to Buy. There are 3,023 funds or institutions reporting positions in Boeing. This ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
03/07/25 | 9.00 | 9.07 | 9.00 | 9.03 | 5,809 |
02/07/25 | 8.84 | 9.32 | 8.72 | 9.265 | 8,680 |
01/07/25 | 8.97 | 8.97 | 8.58 | 8.85 | 6,436 |
30/06/25 | 8.85 | 8.98 | 8.4901 | 8.58 | 24,549 |
27/06/25 | 8.10 | 8.75 | 8.0301 | 8.68 | 11,505 |
26/06/25 | 8.63 | 8.63 | 7.62 | 8.38 | 6,820 |
25/06/25 | 8.47 | 8.7399 | 8.46 | 8.595 | 7,953 |
24/06/25 | 8.07 | 8.47 | 8.07 | 8.47 | 8,713 |
23/06/25 | 7.30 | 8.06 | 7.30 | 8.06 | 17,740 |
20/06/25 | 7.50 | 7.747 | 7.11 | 7.66 | 13,400 |
|
|
||||
|
|
||||
|
|